Title

探討機能性深層海洋飲用水於高油脂/ 膽固醇飲食下的保健功能-心血管與肝臟

Translated Titles

Protective Effects of Functional Deep-Seawater Drinking Water on Cardiovascular and Hepatic Health in a High- Fat/Cholesterol Dietary Habit

DOI

10.6834/CSMU.2009.00103

Authors

王瑜

Key Words

深層海洋水 ; 機能性深層海洋飲用水 ; 礦物質 ; 鈣 ; 鎂 ; 心血管疾病 ; 脂肪肝 ; Deep-seawater ; Functional deep-seawater drinking water ; Mineral ; Calcium ; Magnesium ; Cardiovascular disease ; Fatty liver

PublicationName

中山醫學大學營養學研究所學位論文

Volume or Term/Year and Month of Publication

2009年

Academic Degree Category

碩士

Advisor

陳億乘

Content Language

繁體中文

Chinese Abstract

本實驗欲探討在高油脂/膽固醇(12%油脂/ 0.2%膽固醇)飲食習慣下,飲用機能性深層海洋飲用水(Functional deep-seawater drinking water)對於心血管與和肝臟的保健功效。實驗動物為四十八隻五週齡大的雄性倉鼠(Syrian Golden hamsters),先飼養一週適應環境,一週後皆給予高油脂/膽固醇飲食(12%油脂/ 0.2%膽固醇),並隨機分成四組,每組十二隻雄性倉鼠,組別如下:一) NDW:飲用一般蒸餾水(Normal distilled water);二) DSW300:飲用硬度為300ppm機能性深層海洋飲用水(300ppm deep-seawater drinking water);三) DSW900:飲用硬度為900ppm機能性深層海洋飲用水(900ppm deep-seawater drinking water);四) DSW1500:飲用硬度為1500ppm機能性深層海洋飲用水(1500ppm deep-seawater drinking water)。實驗六週後發現飲用DSW drinking water組別皆可降低血清中總膽固醇(TC)和三酸甘油酯(TAG)含量(P<0.05),與改善粥狀動脈硬化指數(AI) (P<0.05);同時還可以降低肝臟中的總脂質含量(TC與TAG) (P<0.05),與增加糞便中總脂質(TC與TAG)和膽酸的排泄(P<0.05)。另外還發現飲用DSW drinking water有減少肝功能指數(AST與ALT) (P<0.05);改善血清中(MDA與TEAC)和肝臟中(MDA、GSH與TEAC)的抗氧化能力(P<0.05)。在體內膽固醇恆定(Cholesterol homeostasis)相關基因表現:飲用DSW drinking water可使肝臟中LDLR mRNA表現量增加(P<0.05),但並沒有影響肝臟中HMG-CoAR mRNA表現量(P>0.05),另外只有在飲用DSW1500有提高肝臟中CYP7A1 mRNA表現量(P<0.05)。體內脂肪酸與三酸甘油酯恆定(Fatty acid and triacylglycerol homeostasis)相關基因表現:肝臟中SREBP-1、ACC、FAS與ME mRNA表現量並沒有受到飲用DSW drinking water所影響(P>0.05)。能量代謝(Energy metabolism)相關基因表現:飲用DSW drinking water使肝臟中PPAR-α mRNA表現量增加,又以飲用DSW1500表現最顯著(P<0.05)。本實驗結果指出,飲用機能性深層海洋飲用水可減緩於高油脂/膽固醇飲食下所造成的心血管損傷和肝損傷。

English Abstract

Deep-seawater (DSW) is defined as the sea water at depths below 200 meters. It is pure and rich in mineral contents, i.e. calcium (Ca), magnesium (Mg), and potassium (K). Decreasing hardness of DSW is necessary for a functional DSW drinking water development; meanwhile the mineral contents in DSW are also decreased. Thus, the protective effects of functional DSW drinking water on hyperlipidemia and fatty liver induced by a high-fat/cholesterol dietary habit warrant a further study. After one week of accumulation, 48 male Syrian Golden hamsters (5-wk age) fed a high fat/cholesterol diet (12% fat/ 0.2% cholesterol) was used as the animal model which were assigned to 4 different drinking groups randomly: 1) NDW: normal distilled water; 2) DSW300: 300ppm deep-seawater drinking water; 3) DSW900: 900ppm deep-seawater drinking water; 4) DSW1500: 1500ppm deep-seawater drinking water. The experiment lasted for 6 weeks. Lower (P<0.05) serum TC, TAG, and atherogenic index (AI), as well as hepatic TC and TAG were observed in three functional DSW-drinking-water groups when compared to those of the NDW group. The higher (P<0.05) fecal total lipid (TC and TAG) and bile acid excretions were measured in functional DSW-drinking-water groups. Meanwhile, hepatic LDLR, CYP7A1, and PPAR-α gene expressions were upregulated (P<0.05) by drinking functional DSW-drinking-water. Moreover, functional DSW-drinking-water improved (P<0.05) serum and hepatic lipoperoxide index (MDA) and antioxidant indices (TEAC and GSH), as well as lowered (P<0.05) liver functional indices (AST and ALT) which showed a cardiovascular and hepatic protection, respectively. It was concluded that hypolipidemic effect of DSW drinking water might be due to upregulations of LDLR, CYP7A1, and PPAR-α gene expressions, and higher fecal total lipid and bile acid excretions. Functional DSW-drinking-water also improve serum and hepatic antioxidant capacities. Via this study, 900 or 1500ppm DSW drinking water is worth to develop as an ingredient of cardioprotective and hepatoprotective drinks in the future.

Topic Category 醫藥衛生 > 預防保健與衛生學
健康管理學院 > 營養學研究所
Reference
  1. 李立柏與張文宇,2004年,高醫醫訊月刊第二十四卷第七期。
    連結:
  2. Abels, D. J., Even-Paz, Z., and Efron, D. (1996). Bioclimatology at the Dead Sea in
    連結:
  3. Israel. Clinical in Dermatology 14, 653-658.
    連結:
  4. journal of haematology 50, 206-212.
    連結:
  5. plasma malondialdehyde levels in patients with early breast cancer. Cancer
    連結:
  6. Detection and Prevention 27, 122-126.
    連結:
  7. metabolism and resistance to dietary cholesterol in LXRβ-deficient mice. The
    連結:
  8. liver disease and the severity of coronary artery disease in patients with
    連結:
  9. Gastroenterology Hepatology 18, 588-594.
    連結:
  10. Angulo, P. (2002). Nonalcoholic fatty liver disease. The New England Journal of
    連結:
  11. Aoyama, K., Watabe, M., and Nakaki, T. (2008). Regulation of neuronal glutathione
    連結:
  12. during fat digestion in human stomach and duodenum. American Journal of
    連結:
  13. Arner, P., and Langin, D. (2007) The role of neutral lipases in human adipose tissue
    連結:
  14. lipolysis, Current Opinion in Lipidology. 18, 246-250.
    連結:
  15. (2003). A critical appraisal of the use of the antioxidant capacity (TEAC) assay in
    連結:
  16. (2002). Nitric oxide levels and lipid peroxidation in plasma of patients with
    連結:
  17. (2003). Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide
    連結:
  18. concentrations in serum of patients with chronic lymphocytic leukemia. Clinica
    連結:
  19. Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in
    連結:
  20. . Methoden der Enzymatischen Analyse, (ed.), pp 769-775.
    連結:
  21. symptomatic hyponatremia after outpatient surgery. Anesthesia and Analgesia 98, 1294–1296.
    連結:
  22. Journal of Nephrology 15, 225-229.
    連結:
  23. Circadian variation of white blood cell aggregation and free radical indices in
    連結:
  24. men with ischaemic heart disease. European Heart Journal 13, 1632–1636.
    連結:
  25. Brockman, H. L. (2000). Kinetic behavior of the pancreatic lipase-colipase-lipid
    連結:
  26. system. Biochimie 82, 987-995.
    連結:
  27. have more than one staff mode of operation? Nature 315, 21-26.
    連結:
  28. cholesterol metabolism by proteolysis of a membrane-bound transcription
    連結:
  29. a subtype selective human PPAR-α agonist through parallel-array synthesis.
    連結:
  30. Bioorganic and Medicinal Chemistry Letters 11, 1225-1227.
    連結:
  31. Browning, J. D., and Horton, J. D. (2004). Molecular mediators of hepatic steatosis
    連結:
  32. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.
    連結:
  33. oxidative stress, and aging. Free Radical Biology and Medicine 29, 222-230.
    連結:
  34. plasma antioxidant capacity after consumption of controlled diets high in fruit
    連結:
  35. Cao, G., Sofic, E., and Prior, R. L. (1996). Antioxidant capacity of tea and common
    連結:
  36. vegetables. Journal of Agricultural and Food Chemistry 44, 3426-3431.
    連結:
  37. the progression of non-alcoholic fatty liver disease in obese rats. The Federation
    連結:
  38. of American Societies for Experimental Biology 19, 136-138.
    連結:
  39. Catalá, A. (2006). An overview of lipid peroxidation with emphasis in outer segments
    連結:
  40. Catalá, A. (2009). Lipid peroxidation of membrane phospholipids generates
    連結:
  41. hydroxy-alkenals and oxidized phospholipids active in physiological and/or
    連結:
  42. Human fatty acid synthase: structure and substrate selectivity of the thioesterase
    連結:
  43. hypertension and drinking water quality. Epidemiology 18, 109-109.
    連結:
  44. changes in omega-3-enhanced farmed rainbow trout (Oncorhynchus mykiss)
    連結:
  45. Chiang, J. Y. L. (2002). Bile acid regulation of gene expression: roles of nuclear
    連結:
  46. Chiu, H. F., Chang, C. C., and Yang, C. Y. (2004). Magnesium and calcium in
    連結:
  47. Cohen, H., Sherer, Y., Shaish, A., Shoenfeld, Y., Levkovitz, H., Bitzur, R., and Harats, D. (2002). Atherogenesis inhibition induced by magnesium-chloride fortification
    連結:
  48. Coleman, R. A., and Lee, D. P. (2004). Enzymes of triacylglycerol synthesis and their
    連結:
  49. of long-chain fatty acyl-CoA esters in beta-cell signal transduction. Journal of
    連結:
  50. Nutrition 130, 299-304.
    連結:
  51. Cavallaro, A. (2006). High density lipoproteins downregulate basic fibroblast
    連結:
  52. muscle cells. Atherosclerosis 189, 303-309.
    連結:
  53. and Brown, R. H. (1999). The pharmacokinetics and pharmaco-dynamics
    連結:
  54. of procysteine in amyotrophic lateral sclerosis. Neurology 52, 1492-1494.
    連結:
  55. (1997). Additive hypocholesterolemic effect of psyllium and cholestyramine in
    連結:
  56. Clinical Biochemistry 35, 137-141.
    連結:
  57. damage, total antioxidant capacity and coronary artery disease. Mutation
    連結:
  58. Research 570, 197-203.
    連結:
  59. Despres, J. P., and Lemieux, I. (2008). Abdominal obesity and the metabolic
    連結:
  60. syndrome. Contribution to Global Cardiometabolic Risk. American Heart Association
    連結:
  61. Keenoy, B. M. (2003). Oxidative stress status in patients with diabetes mellitus:
    連結:
  62. Dipple, K. M., Zhang , Y. H., Huang, B. L., McCabe, L. L., Dallongeville, J., and
    連結:
  63. Inokuchi, T. (2001). Glycerol kinase deficiency: Evidence for complexity in a
    連結:
  64. Dringen, R. (2000) Metabolism and functions of glutathione in brain. Progress in
    連結:
  65. Neurobiology 62, 649-671.
    連結:
  66. Dringen, R., and Hirrlinger, J. (2003). Glutathione Pathways in the Brain. Biological
    連結:
  67. Dröge, W., and Breitkreutz, R. (2000), Glutathione and immune function.
    連結:
  68. Proceedings of the Nutrition Society 59, 595–600.
    連結:
  69. screening in chronic pancreatitis. The American Journal of Gastroenterology 99,
    連結:
  70. Regulation of lipolysis in adipocytes, Annual Review of Nutrition 27, 79–101.
    連結:
  71. Eaton, S. (2002). Control of mitochondrial β-oxidation flux. Progress in Lipid
    連結:
  72. magnesium sulfate and EDTA in the hypercholesterolaemic rabbit. Diabetes,
    連結:
  73. Obesity, and Metabolism 3, 417-422.
    連結:
  74. lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by
    連結:
  75. Finkel, T., and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of
    連結:
  76. synthetase is derived from glutathione synthetase by gene duplication. Plant
    連結:
  77. Physiology 126, 1706-1715.
    連結:
  78. Freud, R. J., and Wilson, W. J. (1997). Design of experiments. In Statistical methods.
    連結:
  79. hydroxylase and mutations causing vitamin D-dependent rickets type 1.
    連結:
  80. Molecular Endocrinology 11, 1961-1970.
    連結:
  81. increase lipid peroxidation and synergistically trigger hepatic cytokine
    連結:
  82. expression in a transgenic mouse model. Journal of hepatology 39, 1020-1027.
    連結:
  83. Giblin, F. J. (2000). Glutathione: a vital lens antioxidant. Journal of Ocular
    連結:
  84. Pharmacology and Therapeutics 16, 121-135.
    連結:
  85. Givens, M. H. (1917). Studies in calcium and magnesium metabolism. Ⅲ. The effect
    連結:
  86. (MDA) levels in breast and lung cancer patients. Journal of Clinical Pharmacy
    連結:
  87. Gutteridge, J. M. C. (1995). Lipid peroxidation and antioxidants as biomarkers of
    連結:
  88. tissue aamage. Clinical Chemistry 41, 1819-1828.
    連結:
  89. hormone-sensitive lipase, Current Opinion in Lipidology 14, 289-297.
    連結:
  90. Halliwell, B. (2000). Lipid peroxidation, antioxidants and cardiovascular disease: how
    連結:
  91. should we move forward? Cardiovascular Research 47, 410-418.
    連結:
  92. Zheng, Y. N., and Okuda, H. (2001). Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. International Journal of Obesity 25, 1459-1464.
    連結:
  93. restores mineral imbalance in atopic eczema/dermatitis syndrome. European
    連結:
  94. Orlistat in the long-term treatment of obesity in primary care settings. Archives
    連結:
  95. Havel, R. J. (1997). Postprandial lipid metabolism: an overview. Proceedings of the
    連結:
  96. Higueras, V., Raya, A., Rodrigo, J. M., Serra, M. A., Roma, J., and Romero
    連結:
  97. F. J. (1994). Interferon decreases serum lipid peroxidation products
    連結:
  98. of hepatitis C patients. Free Radical Biology and Medicine 15, 131-133.
    連結:
  99. Hadváry, P., and Beglinger, C. (1998). Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 114, 123-129.
    連結:
  100. Hong, Y. L., Yeh, S. L., Chang, C. Y., and Hu, M. L. (2000). Total plasma
    連結:
  101. malondialdehyde levels in 16 Taiwanese college students determined by various
    連結:
  102. chromatography-based method. Clinical Chemistry 33, 619-625.
    連結:
  103. Horton, J. D. (2002). Sterol regulatory element-binding proteins: transcriptional
    連結:
  104. complete program of cholesterol and fatty acid synthesis in the liver. Journal of
    連結:
  105. Clinical Investigation 109, 1125-1131.
    連結:
  106. Hsu, P. K., Chien, P. J., Chen, C. H., and Chau, C. F. (2006). Carrot insoluble
    連結:
  107. fiber-rich fraction lowers lipid and cholesterol absorption in hamsters. Swiss
    連結:
  108. Society of Food Science and Technology 39, 337-342.
    連結:
  109. (Eucommia ulmoides Oliv.) leaves inhibits CCl4-induced hepatic damage in rats.
    連結:
  110. Food Chemistry 44, 1424-1431.
    連結:
  111. Hwang, H. S., Kim, S. H., Yoo, Y. G., Chu, Y. S., Shon, Y. H., Nam, K. S., and
    連結:
  112. Yun, J. W. (2009a). Inhibitory effect of deep-sea water on differentiation of
    連結:
  113. 3T3-L1 adipocytes. Marine Biotechnology 11, 161-168.
    連結:
  114. antidiabetic effects of deep sea water on ob/ob mice. Marine Biotechnology 13,
    連結:
  115. the National Academy of Science 92, 3096-3099.
    連結:
  116. hypercholesterolemic effect of cod protein is reduced in the presence of high
    連結:
  117. James, O. F. L., and Day, C. P. (1998). Non-alcoholic steatohepatitis (NASH): a
    連結:
  118. Jang , Y. C., and Remmen, H. V. (2009). The mitochondrial theory of aging: insight
    連結:
  119. from transgenic and knockout mouse models. Experimental Gerontology 44,
    連結:
  120. The effect of magnesium supplementation on blood pressure: a meta-analysis of
    連結:
  121. randomized clinical trials. American Journal of Hypertension 15, 691-696.
    連結:
  122. by the plasma high density lipoprotein or apolipoprotein A-I concentration. The
    連結:
  123. Journal of Lipid Research 39, 2143-2149.
    連結:
  124. Jonas, A. (2000). Lecithin cholesterol acyltransferase. Biochimica et Biophysica Acta
    連結:
  125. 1529, 245-256.
    連結:
  126. Kalhan, S. C., Mahajan, S., Burkett, E., Reshef, L., and Hanson, R. W. (2001).
    連結:
  127. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol
    連結:
  128. (2003). Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian Journal of Medical Research 118, 178-181.
    連結:
  129. of noninvasive measurement of blood pressure in hamsters. Journal of
    連結:
  130. experimental animals science 52, 359-363.
    連結:
  131. cardiovascular hemodynamics in Kurosawa and Kusanagi-hypercholesterolemic
    連結:
  132. (KHC) Rabbits. Biological and Pharmaceutical Bulletin 31, 38-44.
    連結:
  133. solubilization behavior during in vitro digestion of simple triglyceride lipid
    連結:
  134. Kersten, S., Desvergne, B., and Wahil, W. (2000). Roles of PPARs in health and
    連結:
  135. disease. Nature 405, 421-424.
    連結:
  136. radical damage. Alternative Medicine Review 2, 155-176.
    連結:
  137. sea water in patients with atopic eczema/dermatitis syndrome (AEDS). Acta
    連結:
  138. McCabe, E. R. B. (2001). Glycerol kinase deficiency: evidence for complexity in a single gene disorder. Human Genetics 109, 55-62.
    連結:
  139. erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in
    連結:
  140. cervical cancer patients. Clinica Chimica Acta 326, 143-149.
    連結:
  141. Kosower, N. S., and Kosower, E. M. (1978). The glutathione status of cells.
    連結:
  142. International Review of Cytology 54, 109-160.
    連結:
  143. level of urinary thiobarbituric acid reactant in healthy humans under different
    連結:
  144. physiological conditions. Biological and pharmaceutical bulletin 17, 1645-1650.
    連結:
  145. acid reactivity of human urine as a possible consequence of lipid peroxidation.
    連結:
  146. Lipids 28, 337-343.
    連結:
  147. pancreatic lipase gene transfer to rat bile: gene therapy of fat malabsorption.
    連結:
  148. American Journal of Physiology Gastrointestinal 279, 1031-1036.
    連結:
  149. (1997). The molecular pathology of lecithin: cholesterol acyltransferase (LCAT)
    連結:
  150. miesyndrom. Zentralblatt fuer Innere Medizin 44, 105-127.
    連結:
  151. and irreversible inactivation of catalase in presence of hydrogen peroxide.
    連結:
  152. Biochimica et Biophysica Acta 1295, 222-238.
    連結:
  153. Grant, R. T., and Breitbart, A. S. (2003). Biological alchemy: engineering bone
    連結:
  154. in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. The Korean Journal of Internal Medicine 13, 12-14.
    連結:
  155. of PPAR-α in energy metabolism and vascular homeostasis. The Journal of
    連結:
  156. Clinical Investigation 116, 571-580.
    連結:
  157. Liao, J. K. (2005). Effects of statins on 3-hydroxy-3-methyglutaryl coenzyme A
    連結:
  158. reductase inhibition beyond low-density lipoprotein cholesterol. The American
    連結:
  159. Journal of Cardiology 96, 24-33.
    連結:
  160. Lim, M. L. (2001). A perspective on tropical sprue. Current Gastroenterology Reports
    連結:
  161. fat diet-induced obesity and leptin resistance in C57Bl/6J mice. International
    連結:
  162. Journal of Obesity 24, 639-646.
    連結:
  163. M. (2007). Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL
    連結:
  164. Loguercio, C., and Federico, A., (2003). Oxidative stress in viral and alcoholic
    連結:
  165. hepatitis. Free Radical Biology and Medicine 34, 1-10.
    連結:
  166. determination in high-density lipoproteins separated by three different methods.
    連結:
  167. Clinical Chemistry 23, 882-884.
    連結:
  168. Lowe, M. E. (2002). The triglyceride lipases of the pancreas. The Journal of Lipid
    連結:
  169. Lu, K., Lee, M. H., and Patel, S. B. (2001). Dietary cholesterol absorption: more
    連結:
  170. than just bile. Trends in Endocrinology and Metabolism 12, 314-320.
    連結:
  171. Lum, H., and Roebuck, J. A. (2001). Oxidant stress and endothelial cell dysfunction.
    連結:
  172. Luyckx, F. H., Lefebvre, P. J., and Scheen, A. J. (2000). Non-alcoholic steatohepatitis:
    連結:
  173. Mitochondrial dysfunction, oxidative stress and neurodegeneration. Journal of
    連結:
  174. Alzheimer`s disease 10, 59-73.
    連結:
  175. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    連結:
  176. Hepatology 37, 917-923.
    連結:
  177. Marnett , L. J. (1999). Lipid peroxidation-DNA damage by malondialdehyde
    連結:
  178. Marnett , L. J. (2002). Oxy radicals, lipid peroxidation and DNA damage. Toxicology 181, 219-222.
    連結:
  179. acids in regulating food intake and cholecystokinin release in humans. Gut 46,
    連結:
  180. calcium-blood pressure debate. Journal of the American College of Nutrition 18,
    連結:
  181. Mccarron, D. A., and Reusser, M. E. (2001). Are low intakes of calcium and potassium important causes of cardiovascular disease? American Journal of
    連結:
  182. FitzGerald, G. A. (1999). Alcohol-induced generation of lipid peroxidation
    連結:
  183. products in humans. The American Society for Clinical Investigation 104,
    連結:
  184. Journal of Biological Chemistry 263, 17205-17208.
    連結:
  185. liver function in Mediterranean spotted fever. Le Infezioni in Medicina 15,
    連結:
  186. and obese patients with type 2 diabetes treated with metformin. Diabetes Care 25,
    連結:
  187. A novel method for measuring antioxidantcapacity and its application to
    連結:
  188. monitoring the antioxidant status in premature neonatoes. Clinical Science 84,
    連結:
  189. Difference between deep seawater and surface seawater in the preventive effect
    連結:
  190. of atherosclerosis. Biological and Pharmaceutical Bulletin 27, 1784-1787.
    連結:
  191. of epidemiological studies on drinking water hardness and cardiovascular
    連結:
  192. diseases. European Journal of Cardiovascular Prevention and Rehabilitation 13,
    連結:
  193. Matsuzaki, S. (2002). Assessment of a difference in ALDH2 heterozygotes and
    連結:
  194. alcoholic liver injury. Alcoholism, Clinical and Experimental Research 26,
    連結:
  195. regulator of mitochondrial hydrogen peroxide generation. The Federation of
    連結:
  196. American Societies for Experimental Biology 11, 809-815.
    連結:
  197. influence of calcium and magnesium in drinking water and diet on
    連結:
  198. cardiovascular risk factors in individuals living in hard and soft water areas with
    連結:
  199. differences in cardiovascular mortality. BMC Public Health 3, 21-30.
    連結:
  200. Niedernhofer, L. J., Daniels, J. S., Rouzer, C. A., Greene, R. E., and Marnett, L. J.
    連結:
  201. (2003). Malondialdehyde, a product of lipid peroxidation, Is mutagenic in human
    連結:
  202. as a model of experimental atherosclerosis 68, 159-173.
    連結:
  203. Nojiri, S., Daida, H., Mokuno, H., Iwama, Y., Mae, K., Ushio, F., and Ueki, T. (2001). Association of serum antioxidant capacity with coronary artery disease in
    連結:
  204. Noy, Y., and Sklan, D. (2001). Yolk and exogenous feed utilization in the posthatch chick. Poultry Science 80, 1490-1495.
    連結:
  205. and AbdeI-Aleem, S. (1999). Depletion of total antioxidant capacity in type 2
    連結:
  206. diabetes. Metabolism 48, 1414-1417.
    連結:
  207. Petraccia, L., Liberati, G., and Masciullo, S. G. (2006). Water, mineral waters and
    連結:
  208. oil. Hepatology 27, 1317-1323.
    連結:
  209. cycle are induced by Candida albicans during macrophage infection. Life
    連結:
  210. Science 20, 723-730.
    連結:
  211. magnesium-rich Dead Sea salt solution improves skin barrier function, enhances
    連結:
  212. Journal of Dermatology 44, 151-157.
    連結:
  213. Plasma fatty acid changes and increased lipid peroxidation in patients with adult
    連結:
  214. respiratory distress syndrome. Critical Care Medicine 24, 241-246.
    連結:
  215. Raha, S., and Robinson, B. H. (2000). Mitochondria, oxygen free radicals, disease and ageing. Trends in Biochemical Sciences 25, 502-508.
    連結:
  216. Ray, G., and Husain, S. A. (2002). Oxidants, antioxidants and carcinogenesis. Indian
    連結:
  217. (1999). Antioxidant activity applying an improved ABTS radical cation
    連結:
  218. Reaven, G. M. (1993). Role of insulin resistance in human disease (syndrome X): an
    連結:
  219. Redgrave, T.G. (2004). Chylomicron metabolism. Biochemical Society Transaction
    連結:
  220. 32, 79-82.
    連結:
  221. supplementation on serum lipid concentrations in normal older women: a
    連結:
  222. randomized controlled trial. American Journal of Medicine 112, 343-347.
    連結:
  223. Repa, J. J., Buhman, K. K., Farese, R. V., Dietschy, J. M., and Turley, S. D. (2004).
    連結:
  224. ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse:
    連結:
  225. impact on hepatic cholesterol homeostasis. Liver biology and pathobiology 40,
    連結:
  226. regulation of cholesterol homeostasis. Annual Review of Cell and
    連結:
  227. Developmental Biology 16, 459-481.
    連結:
  228. Rice-Evans, C., and Miller, N. J. (1994). Total antioxidant status in plasma and body
    連結:
  229. fluids . Methods Enzymology 234, 279–293.
    連結:
  230. malondialdehyde as toxic molecule and biological marker of oxidative stress.
    連結:
  231. Nutrition, Metabolism and Cardiovascular Diseases 15, 316-328.
    連結:
  232. and Collins, D. (2003). Insulin resistance and cardiovascular events with low
    連結:
  233. HDL cholesterol. Diabetes Care 26, 1513-1517.
    連結:
  234. and Roma, J. (1998). Lipid peroxidation products and antioxidants in human
    連結:
  235. disease. Environmental Health Perspectives 106, 1229-1234.
    連結:
  236. Rubenowitz, E., Axelsson, G., and Rylander, R. (1996). Magnesium in drinking water
    連結:
  237. and death from acute myocardial infarction. American Journal of Epidemiology
    連結:
  238. and long-chain fatty acids, in long-term home parenteral nutrition: a double-blind
    連結:
  239. in the pathophysiology of type 2 diabetes. Annals of Surgery 244, 741-749.
    連結:
  240. Rylander, R. (2008). Drinking water constituents and disease. Journal of Nutrition
    連結:
  241. Rylander, R., and Arnaud, M. J. (2004). Mineral water intake reduces blood pressure
    連結:
  242. among subjects with low urinary magnesium and calcium levels. BMC Public
    連結:
  243. Health 4, 56-61.
    連結:
  244. Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., Karanja, N.,
    連結:
  245. the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium
    連結:
  246. Collaborative Research Group. The New England Journal of Medicine 344, 3-10.
    連結:
  247. Polyphenolic flavonols as scavengers of aqueous phase radicals and as
    連結:
  248. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial
    連結:
  249. abnormalities. Gastroenterology 120, 1183-1192.
    連結:
  250. oxidative stress and neurodegeneration. European Journal of Biochemistry 267,
    連結:
  251. In situ detection of lipid peroxidation and oxidative DNA damage in
    連結:
  252. non-alcoholic fatty liver diseases. Journal of Hepatology 37, 56-62.
    連結:
  253. Shelness, G. S., and Sellers, J. A. (2001). Very-low-density lipoprotein Current
    連結:
  254. Opinion in lipidology assembly and secretion, Current Opinion in Lipidology.
    連結:
  255. Shen, S. C., Lee, W. R., Lin, H. Y., Huang, H. C., Ko, C. H., Yang, L. L.,
    連結:
  256. prostaglandin E2 production. European Journal of Pharmocology 446, 187-194.
    連結:
  257. Sheth, S. G., Gordon, F. D., and Chopra, S. (1997). Nonalcoholic steatohepatitis.
    連結:
  258. Annals of Internal Medicine 126, 137-145.
    連結:
  259. massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
    連結:
  260. Journal of Clinical Investigation 98, 1575-1584.
    連結:
  261. Impairment of intestinal glutathione synthesis in patients with inflammatory
    連結:
  262. Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Experimental Physiology
    連結:
  263. 82, 291-295.
    連結:
  264. Sies, H. (1999). Glutathione and its role in cellular functions. Free Radical Biology
    連結:
  265. and Medicine 82, 291-295.
    連結:
  266. malondialdehyde in diabetes mellitus Diabetologia 43, 550-557.
    連結:
  267. derivative as a potential cross-link from malondialdehyde in physiological
    連結:
  268. systems. FEBS Letters 421, 180-184.
    連結:
  269. relevance to the chronotherapy of cancer. Chronobiology International 8,
    連結:
  270. absorption and bile acid transporter gene message in the hamster ileum.
    連結:
  271. Angulo, P. (2005). Effect of changes on body weight and lifestyle in
    連結:
  272. nonalcoholic fatty liver disease. Journal of Hepatology 43, 1060-1066.
    連結:
  273. Havekes, L.M. (2003). Contribution of fatty acids released from lipolysis of
    連結:
  274. pathophysiology of hypertension in humans and animals. American Journal of
    連結:
  275. Clinical Nutrition 65, 606-611.
    連結:
  276. Toth, P. P. (2008). Subclinical atherosclerosis: what it is, what it means and what we can do about it. International Journal of Clinical Practice 62, 1246-1254.
    連結:
  277. stress in cancer. Federation of European Biochemical Societies 358, 1-3.
    連結:
  278. lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile
    連結:
  279. Trinder, P. (1969). Determination of glucose in blood using glucose oxidase with an
    連結:
  280. alternative oxygen acceptor. Annals of Clinical Biochemistry 6, 24-27.
    連結:
  281. relationship between magnesium in drinking water and liver cancer. Magnesium
    連結:
  282. Tzang, B. S., Yang, S. F., Fu, S. G., Yang, H. C., Sun, H. L., and Chen, Y. C. (2009).
    連結:
  283. Effects of dietary flaxseed oil on cholesterol metabolism of hamsters. Food
    連結:
  284. Ucar, M., Mjörndal, T., and Dahlqvist, R. (2000). HMG-CoA reductase inhibitors and
    連結:
  285. myotoxicity. Drug Safety 22, 441-457.
    連結:
  286. Vague, J. P., Boyer, V. J., and Cloix, M. (1971). Anthropometry of obesity, diabetes.
    連結:
  287. Vance, J. E., and Vance, D. E. (2005). Metabolic insights into phospholipid function
    連結:
  288. best predicts aortic root atherosclerosis in LDL receptor deficient mice. Journal
    連結:
  289. of Lipid Research 50, 376-385.
    連結:
  290. Vaskonen, T. (2003). Dietary minerals and modification of cardiovascular risk factors.
    連結:
  291. (2002). Effects of calcium and plant sterols on serum lipids in obese Zucker rats
    連結:
  292. Vlahcevic, Z. R., Pandak, W. M., and Stravitz, R. T. (1999). Regulation of bile acid
    連結:
  293. Wakil, S. J., and Abu-Elheiga, L. A. (2009). Fatty acid metabolism: target for
    連結:
  294. radical absorbance capacity assay in plasma. Clinical of Chemistry 50, 952-954.
    連結:
  295. Wang, H., Cao, G., and Prior, R. L. (1996). Total antioxidant capacity of fruits.
    連結:
  296. Journal of Agricultural and Food Chemistry 44, 701-705.
    連結:
  297. Oceanography 56, 553-558.
    連結:
  298. And qualitative fecal fat excretion in man. Annual of Nutrition and Metabolism
    連結:
  299. (1997). Effects of oral potassium on blood pressure . Meta-analysis of
    連結:
  300. randomized controlled clinical trials. Journal of the American Medical
    連結:
  301. Association 27, 1624-1632.
    連結:
  302. chemoluminescent assay for antioxidant capacity in biological fluids. Analytica
    連結:
  303. (2009). Chronic, in vivo, PPAR-α activation prevents lipid overload in rat liver
    連結:
  304. Witztum, J. L. (1996). Drugs used in the treatment of hyperlipoproteinemias, In:
    連結:
  305. Hardman, Limbird, Molinoff, Ruddon (Eds.), Goodman & Gilman's The
    連結:
  306. Pharmacological Basis of Therapeutics, 9th ed, McGraw-Hill, New York,
    連結:
  307. metabolism and its implications for health. Journal of Nutrition 134, 489-492.
    連結:
  308. the regulation of lipid accumulation in filamentous fungi. Microbiology 145,
    連結:
  309. fatty acid synthesis. Proceedings of the National Academy of Sciences 100,
    連結:
  310. Yang, C. Y. (1998). Calcium and magnesium in drinking water and risk of death from
    連結:
  311. cerebrovascular disease. American Heart Association 2, 411-414.
    連結:
  312. Yang, C. Y., Chang, C. C., Tsai, S. S., and Chiu, H. F. (2006). Calcium and
    連結:
  313. magnesium in drinking water and risk of death from acute myocardial infarction
    連結:
  314. and nitrate in drinking water and gastric cancer mortality. Japanese Journal of
    連結:
  315. Yang, C. Y., and Chiu, H. F. (1998). Calcium and magnesium in drinking water and
    連結:
  316. Yang, C. Y., and Chiu, H. F. (1999). Calcium and magnesium in drinking water and
    連結:
  317. Yang, C. Y., Chiu, H. F., Cheng, M. F., Hsu, T. Y., Cheng, M. F., and Wu, T. N.
    連結:
  318. (2000b). Calcium and magnesium in drinking water and the risk of death from
    連結:
  319. Yang, C. Y., Chiu, H. F., Chiu, J. F., Tsai, S. S., and Cheng, M. F. (1997). Calcium and
    連結:
  320. magnesium in drinking water and risk of death from colon cancer. Japanese
    連結:
  321. Journal of Cancer Research 88, 928-933.
    連結:
  322. Yang, C. Y., Chiu, H. F., Tsai, S. S., Cheng, M. F., Lin, M. C., and Sung, F. C.
    連結:
  323. (2000a). Calcium and magnesium in drinking water and risk of death from
    連結:
  324. Yang, C. Y., and Hung, C. F. (1998). Colon cancer mortality and total hardness levels
    連結:
  325. in Taiwan’s drinking water. Archives of Environmental Contamination and
    連結:
  326. Toxicology 35, 148-151.
    連結:
  327. expression of peroxisome proliferator-activated receptor-α may have an
    連結:
  328. important role in the development of non-alcoholic fatty liver disease. Journal of
    連結:
  329. Gastroenterology and Hepatology 19, 799-804.
    連結:
  330. (1996). Immunohistochemical detection of 4-hydroxynonenal protein adducts in
    連結:
  331. Parkinson disease. Medical Sciences 93, 2696-2701.
    連結:
  332. hyperlipidemia prevention and medical treatment effect. Biological and
    連結:
  333. (2004). Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clinical
    連結:
  334. Gastroenterology and Hepatology 2, 262-265.
    連結:
  335. Yu, B. P. (1996). Aging and oxidative stress: modulation by dietary restriction. Free
    連結:
  336. Lipolysis: pathway under construction, Current Opinion in Lipidology 16,
    連結:
  337. adiposity by dietary calcium. Federation of American Societies for Experimental
    連結:
  338. metabolic syndrome: a global public health problem and a new definition.
    連結:
  339. Birner-Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F.,
    連結:
  340. Hermetter, A., and Zechner, R. (2004). Fat mobilization in adipose tissue is
    連結:
  341. 行政院衛生署,2008年,中華民國公共衛生概況。
  342. 伍毅嘉,2005年,台灣協和健而康夏季季刊。
  343. 經濟部水利署,2006年,
  344. http://www.wra.gov.tw/ct.asp?xItem=27931&ctNode=5281&comefrom=lp。
  345. 經濟部水利署,2007年,
  346. http://www.wra.gov.tw/ct.asp?xItem=34032&ctNode=5281&comefrom=lp。
  347. Aarsland, A., and Wolfe, R. R. (1998). Hepatic secretion of VLDL fatty acids during
  348. stimulated lipogenesis in men. Journal of Lipid Research 39, 1280–1286.
  349. Abrahamsen, J. F., Smaaland, R., Sandberg, S., Aakvaag, A., and Lote, K. (1993).
  350. Circadian variation in serum cortisol and circulating neutrophils are markers for
  351. circadian variation of bone marrow proliferation in cancer patients. European
  352. Akbulut, H., Akbulut, K. G., Icli, F., and Büyükcelik, A. (2003). Daily variations of
  353. Alberti, S., Schuster, G., Parini, P., Feltkamp, D., Diczfalusy, U., Rudling, M.,Angelin,
  354. B., Björkhem, I., Pettersson, S., and Gustafsson, J. A. (2001). Hepatic cholesterol
  355. journal of Clinical Investigation 107, 565-573.
  356. Alper, A. T., Hasdemir, H., Şahin, Onturk, E., Akyol, A., Nurkalem, Z., Cakmak, N.,
  357. Erdinler, I., and Gurkan, K. (2008). The relationship between nonalcoholic fatty
  358. metabolic syndrome. Turkish Society of Cardiology 36, 376-381.
  359. Angelico, F., Del, B. M., Conti, R., Francioso, S., Feole, K., Maccioni, D.,
  360. Antonini, T. M., and Alessandri, C. (2003). Non-alcoholic fatty liver syndrome:
  361. a hepatic consequence of common metabolic diseases. Journal of
  362. Medicine 346, 1221-1231.
  363. synthesis. Journal of Pharmacological Sciences 108, 227-238.
  364. Armand, M., Borel, P., Pasquier, B., Dubois, C., Senft, M., Andre, M., Peyrot, J.,
  365. Salducci, J.,and Lairon, D. (1996). Physicochemical characteristics of emulsions
  366. Society 271, 172-183.
  367. Arts M. J. T. J., Sebastiaan, D. J., Voss, H. P., Haenen, G. R. M. M., and Bast, A.
  368. defining optimal antioxidant structures. Food Chemistry 80, 409-414.
  369. Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B., and Minuk, G. (2000). Fatty
  370. infiltration of liver in hyperlipidemic patients. Digestive Diseases Sciences 45,
  371. 1929-1934.
  372. Bakan, E., Taysi, S., Polat, M. F., Dalga, S., Umudum, Z., Bakan, N., and Gumus, M.
  373. gastric cancer. Japanese Journal of Clinical Oncology 32, 162-166.
  374. Bakan, N., Taysi, S., Yilmaz, O., Bakan, E., Kuskay, S., Uzun, N., and Gundogdu
  375. dismutase activities, glutathione, nitric oxide, and malondialdehyde
  376. Chimica Acta 338, 143-149.
  377. Bell, T. A., Wilson, M. D., Kelley, K., Sawyer, J. L., and Rudel, L. L. (2007).
  378. human apoB-100 transgenic, LDL–/– mice. Journal of Lipid Research 48,
  379. 1122-1131.
  380. Benzie, I. F. F., and Strain, J. J. (1996). The ferric reducing ability of plasma (FRAP)
  381. as a measure of “antioxidant power”: the FRAP assay. Analytical Biochemistry
  382. 239, 70–76.
  383. Bergmeyer, H. U., and Bernt, E. (1974). Glutamate-oxaloacetate-transaminase
  384. Bhananker, S. M., Paek, F. R., and Vavilala, M. S. (2004). Water intoxication and
  385. Boero, R., Pignataro, A., and Quarello, F. (2002). Salt intake and kidney disease.
  386. Bridges, A. B., Scott, N. A., Mcneill, G. P., Pringle, T. H., and Belch, J. J. F. (1992).
  387. Broecker, W.S., Petert, D.M, and Rind, D. (1985). Does the ocean-atmosphere system
  388. Brown, M. S., and Goldstein, J. L. (1997). The SREBP pathway: regulation of
  389. factor. Cell 89, 331-340.
  390. Brown, P. J., Stuart, L. W., Hurley, K. P., Lewis, M. C., Winegar, D. A., Wilson,
  391. J. G., Wilkison, W. O., Ittoop, O. R., and Willson, T. M. (2001). Identification of
  392. and liver injury. Journal of Clinical Investigation 114, 147-152.
  393. Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A., and Thorens, B. (2002).
  394. American Journal of Physiology 282, 834-842.
  395. Cadenas, E., and Davies, K. J. A. (2000). Mitochondrial free radical generation,
  396. Cao, G., Alessio, H. M., and Culter, R. G. (1993). Oxygen-radical absorbance
  397. capacity assay for antioxidants. Free Radical Biology and Medicine 14, 303-311.
  398. Cao, G., Booth, S. L., Sadowski, J. A., and Prior, R. L. (1998). Increases in human
  399. and vegetables. The Ameican Journal of Clinical Nutrition 68, 1081-1087.
  400. Carmiel-Haggai, M., Cederbaum, A. I., and Nieto, N. (2005). A high-fat diet leads to
  401. of photoreceptors and the chemiluminescence assay. 38, 1482-1495.
  402. pathological conditions. Chemistry and Physics of Lipids 157, 1-11.
  403. Chakravarty, B., Gu, Z., Chirala, S. S., Wakil, S. J., and Quiocho, F. A. (2004).
  404. domain. Proceedings of the National Academy of Sciences 101, 15567-15572.
  405. Chan, C. C., Chen, T. H. S., and Chiu, Y. H. (2007). Association between
  406. Chen, C. W., and Cheng, H. H. (2006). A rice bran oil diet increases LDL-receptor
  407. and HMG-CoA reductase mRNA expression and insulin sensitivity in rats with
  408. streptozotocin/nicotinamide-induced type 2 diabetes. Journal of Nutrition 136,
  409. 1472-1476.
  410. Chen, Y. C., Nguyen, J., Beamer, S. S., and Jaczynski, J. (2007). Physicochemical
  411. muscle during refrigerated storage. Food Chemistry 104, 1143-1152.
  412. hormone receptor. Endocrine Reviews 23, 443-463.
  413. drinking water and risk of death from ovarian cancer. Magnesium Research 17,
  414. 28-34.
  415. of drinking water. Biological Trace Element Research 90, 251-259.
  416. regulation. Progress in Lipid Research 43, 134-176.
  417. Corkey, B. E., Deeney, J. T., Yaney, G. C., Tornheim, K., Prentki, M. (2001). The role
  418. Cucina, A., Scavo, M. P., Muzzioli, L., Coluccia, P., Ceccarini, S., Fuso, A., and
  419. growth factor production and release in minimally oxidated-LDL treated smooth
  420. Cudkowicz, M. E., Sexton, P. M., Ellis, T., Hayden, D. L., Gwilt, P. R.,Whalen, J.,
  421. Daggy, B. P., O'Connell, N. C., Jerdack, G. R., Stinson, B. A., and Setchell, K. D.
  422. the hamster: influence on fecal sterol and bile acid profiles. Journal of Lipid
  423. Research 38, 491-502
  424. Davis, R. A., Miyake, J. H., Hui, T. Y., and Spann, N. J. (2002). Regulation of
  425. cholesterol-7-hydroxylase: barely missing a SHP. Journal of Lipid Research 43,
  426. 533-543.
  427. De, R. B. Z., Gilliland, S. E., and Maxwell, C. V. (1996). Hypocholesterolemic action
  428. of Lactobacillus acidophilus ATCC 4321 and calcium in swine with
  429. hypercholesterolemia induced by diet. Journal of Dairy Science 7, 2121-2128.
  430. Delibas, N., Ozcankaya, R., and Altuntas, I. (2002). Clinical importance of
  431. erythrocyte malondialdehyde levels as a marker for cognitive deterioration in
  432. patients with dementia of Alzheimer type: a repeated study in 5-year interval.
  433. Demirbag, R., Yilmaz, R., and Kocyigit, A. (2005). Relationship between DNA
  434. Derham, B. K., and Harding, J. J. (2002). Effects of modifications of a-crystallin on
  435. its chaperone and other properties. The Journal of Biochemistry 364, 711-714.
  436. 1040-1049.
  437. Dierckx, N., Horvath, G., Gils, C. V., Vertommen, J., Vliet, J., Leeuw, I. D., and
  438. relationship to diet. European Journal of Clinical Nutrition 57, 999–1008.
  439. single gene disorder. Human Genetics 109, 55-62.
  440. Drenick, E. J. (1961). The influence of ingestion of calcium and other soap-forming
  441. substances on fecal fat. Gastroenterology 4, 242-244.
  442. Chemistry 384, 505-516.
  443. Dumasy, V., Delhaye, M., Cotton, F., and Deviere, J. (2004). Fat malabsorption
  444. 1350-1354.
  445. Duncan, R. E., Ahmadian, M., Jaworski, K., Sarkadi-Nagy, E., and Sul, H. S. (2007)
  446. Research 41, 197-239.
  447. Evans, D. A., Tariq, M., Sujata, B., Mccann, G., and Sobki, S. (2001). The effects of
  448. Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A.,
  449. Gross, R. W., and Kelly, D. P. (2003). A critical role for PPAR-α mediated
  450. dietary fat content. Proceedings of the Nutrition Society 100, 1226-1231.
  451. aging. Nature 408, 239-247.
  452. Frendo, P., Jiménez, M. J., Mathieu, C., Duret, L., Gallesi, D., Van, de., Sype, G.,
  453. Hérouart, D., and Puppo, A. (2001). A medicago truncatula homoglutathione
  454. San Diego: Academic Press. (revised ed.) pp. 461-507.
  455. Fu, G. K., Lin, D., Zhang, M. Y. H., Bikle, D, D., Shackleton, C. H. L., Miller, W. L.,
  456. and Portale, A. A. (1997). Cloning of human 25-hydroxyvitamin D-1α-
  457. Gabriel, P., Philippe, L., Francoise, C., Flora, Z., Dominique, P., Bertrand, N., and
  458. Christian, B. (2003). Alcohol and hepatitis C virus core protein additively
  459. of fat and fatty acid derivatives. Journal of Biological Chemistry 3, 441-444.
  460. Gonenc, A., Ozkan, Y., Torun, M., and Simsek, B. (2001). Plasma malondialdehyde
  461. and Therapeutics 26, 41-144.
  462. Haddad, J. J., and Harb, H. L. (2005). L-γ-glutamyl-L-cysteinyl-glycine (glutathione;
  463. GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory
  464. cytokines: a signaling transcriptional scenario for redox(y) immunologic
  465. sensor(s)? Molecular Immunology 42, 987-1014.
  466. Haemmerle, G., Zimmermann, R., and Zechner, R. (2003) Letting lipids go:
  467. Han, L. K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T., Hayashi, T.,
  468. Han, L. K., Takaku, T., Li, J., Kimura, Y., and Okuda, H. (1999). Anti-obesity action
  469. of oolong tea. International Journal of Obesity 23, 98-105.
  470. Hataguchi, Y., Tai, H., Nakajima, H., and Kimata, H. (2005). Drinking deep-sea water
  471. Journal of Clinical Nutrition 59, 1093-1096.
  472. Hauptman, J., Lucas, C., Boldrin, M. N., Collins, H., and Segal, KR. (2000).
  473. of Family Medicine 9, 160-167.
  474. Nutrition Society 56, 659-666.
  475. Hildebrand, P., Petrig, C., Burckhardt, B., Ketterer, S., Lengsfeld, H., Fleury, A.,
  476. thiobarbituric acid tests and an improved high-performance liquid
  477. activators of lipid synthesis. Biochemical Society Transactions 30, 1091-1095.
  478. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002). SREBPs: activators of the
  479. Hung, M. Y., Fu, T. Y., Shih, P. H., Lee, C. P., and Yen, G. C. (2006). Du-Zhong
  480. Hwang, H. S., Kim, H. A., Lee, S. H., and Yun, J. W. (2009b). Anti-obesity and
  481. 2228-2236.
  482. Ikemoto, S., Thompson, K. S., Takahashi, M., Itakura, H., Lane, M. D., and Ezaki, O.
  483. (1995). High fat diet-induced hyperglycemia: Prevention by low level expression
  484. of a glucose transporter (GLUT4) minigene in transgenic mice. Proceedings of
  485. Jacques, H., Lavigne, C., Desrosiers, T., Giroux, I., and Hurley, C. (1995). The
  486. dietary calcium. Canadian Journal of Physiology and Pharmacology 7, 465-473.
  487. disease of emerging identity and importance. Journal of Hepatology 29,495-501.
  488. 256-260.
  489. Jee, S. H., Miller, E. R., Guallar, E., Singh, V. K., Appel, L. J., and Klag, M. J. (2002).
  490. Jolley, C. D., Woollett, L. A., Turley, S. D., and Dietschy, J. M. (1998). Centripetal
  491. cholesterol flux to the liver is dictated by events in the peripheral organs and not
  492. synthesis in humans. The Journal of Biological Chemistry 276, 12928-12931.
  493. Karatas, F., Ozates, I., Canatan, H., Halifeoglu, I., Karatepe, M., and Colakt, R.
  494. Kato, Y., Iwase, M., Kanazawa, H., Nishizawa, T., Zhao, Y. L., Takagi, K.,
  495. Nagata, K., Noda, A., Koike, Y., and Yokota, M. (2003). Validity and application
  496. Katsuda, S. I., Yasukawa, T., Nakagawa, K., Miyake, M., Yamasaki, M., Katahira, K., Mohri, M., Shimizu, T., and Hazama, A. (2008). Deep-sea water improves
  497. Kaukonen, A. M., Boyd, B. J., Porter, C. J. H., and Charman, W. N. (2004). Drug
  498. solution formulations. Pharmaceutical Research 21, 245-253.
  499. Kidd, P. M. (1997). Glutathione: systemic protectant against oxidative and free
  500. Kimata, H., Tai, H., Nakagawa, K., Yokoyama, Y., Nakajima, H., and Ikegami, Y.
  501. (2002). Improvement of skin symptoms and mineral imbalance by drinking deep
  502. Medica 45, 83-84.
  503. Kimura, M., Marx, H. J., Roederer, G. O., Shih, V.,•Yamaguchi, S., Yoshida, I., and
  504. Kolanjiappan, K., Manoharan, S., and Kayalvizhi, M. (2002). Measurement of
  505. Kosugi, H., Enomoto, H., Ishizuka, Y., and Kikugawa, K. (1994). Variations in the
  506. Kosugi, H., Kojima, T., and Kikugawa, K. (1993). Characteristics of the thiobarbituric
  507. Kuhel, D. G., Zheng, S., Tso, P., and Hui, D. Y. (2000). Adenovirus-mediated human
  508. Kuivenhoven, J. A., Pritchard, H., Hill, J., Frohlich, J., Assmann, G., and Kastelein, J.
  509. deficiency syndromes. Journal of Lipid Research 38, 191-205.
  510. Kylin, E. (1923). Studien ueber das hypertonie-hyperglyka¨mie- hyperurika¨
  511. Lardinois, O. M., Mestdagh, M. M., and Rouxhet, P. G. (1996). Reversible inhibition
  512. Lee, J. A., Parrett, B. M., Conejero, J. A., Laser, J., Chen, J., Kogon, A. J., Nanda, D.,
  513. and fat from fat-derived stem cells. Annals of Plastic Surgery 50, 610-617.
  514. Lee, J. H., Rhee, P. L., Lee, J. K., Lee, K. T., Kim, J. J., Koh, K. C., Paik, S. W., Rhee, J. C., and Choi, K. W. (1998). Role of hyperinsulinemia and glucose intolerance
  515. Lee, P. C. W., Nguyen, A. D., and DeBose-Bo, R. A. (2007). Mutations within the
  516. membrane domain of HMG-CoA reductase confer resistance to sterol -
  517. accelerated degradation. Journal of Lipid Research 48, 318-327.
  518. Lefebvre, P., Chinetti, G., Fruchart, J. C., and Staels, B. (2006). Sorting out the roles
  519. Lieber, C. S. (2004). Alcoholic fatty liver: its pathogenesis and mechanism of
  520. progression to inflammation and fibrosis. Alcohol 34, 9-19.
  521. 3, 322-327.
  522. Lin, S., Thomas, T. C., Storlien, L. H., and Huang, X. F. (2000). Development of high
  523. Loeffler, B., Heeren, J., Blaeser, M., Radner, H., Kayser, D., Aydin, B., and Merkel,
  524. receptor. Journal of Lipid Research 48, 288-298.
  525. Lopes-Virella, M. F., Stone, P., Ellis, S., Colwell, J. A. (1977). Cholesterol
  526. Research 43, 2007-2016.
  527. Lu, T. T., Makishima, M., Repa, J. J., Schoonjan, K., Kerr, T. A., Auwerx, J., and
  528. Mangelsdorf, D. J. (2000). Molecular basis for feedback regulation of bile
  529. acid synthesis by nuclear receptors. Cell 6, 507-515.
  530. Cell 280, 719-741.
  531. association with obesity and insulin resistance, and influence of weight loss.
  532. Diabetes and Metabolism 26, 98-106.
  533. Mahabadi, A. A., Massaro, J. M., Rosito, G. A., Levy, D., Murabito, J. M., Wolf, P.
  534. A., O’Donnell, C. J., Fox, C. S., and Hoffmann, U. (2009). Association of
  535. pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular
  536. disease burden: the Framingham Heart Study. European Heart Journal.
  537. Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M.,
  538. Haussler, M. R., and Mangelsdorf, D. J. (2002). Vitamin D receptor as an
  539. intestinal bile acid sensor. Science 296, 1313-1316.
  540. Mancuso, M., Coppedè, F., Migliore,L., Siciliano, G., and Murri, L. (2006).
  541. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R.,
  542. Natale, S., Vanni, E., Villanova, N., Melchionda, N., and Rizzetto, M. (2003).
  543. Mutation Research 424, 83-95.
  544. Matsubara, M., Maruoka, S., and Katayose, S. (2002). Decreased plasma adiponectin
  545. concentrations in women with dyslipidemia. The Journal of Endocrinology and
  546. Metabolism 87, 2764-2769.
  547. Matzinger, D., Degen, L., Drewe, J., Meuli, J., Duebendorfer, R., Ruckstuhl, N.,
  548. Amato, M. D., Rovati, L., and Beglinger, C. (2000). The role of long chain fatty
  549. 688-693.
  550. Mccarron, D. A., and Reusser, M. E. (1999). Finding consensus in the dietary
  551. 398-405.
  552. Hypertension-Kidlington 14, 206-212.
  553. Meagher, E. A., Barry, O. P., Burke, A., Lucey, M. R., Lawson, J. A., Rokach, J., and
  554. 805-813.
  555. Meister, A. (1988). Glutathione metabolism and its selective modification. The
  556. Micalizzi, A., La-Spada, E., Corsale, S., Arculeo, A., La-Spada, M., Quartararo, P.,
  557. Giannitrapani, L., Soresi, M., Affronti, M., and Montalto, G. (2007). Abnormal
  558. 105-110.
  559. Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M.,
  560. Foreyt, J., Aronne, L., and Klein, S. (2002). Effect of orlistat in overweight
  561. 1123-1128.
  562. Miller, N. J., Rice-Evans, C., Davies, M. J., Gopinathan, V., and Milner, A. (1993).
  563. 407-412.
  564. Miyamura, M., Yoshioka, S., Hamada, A., Takuma, D., Yokota, J., Kusunose, M.,
  565. Kyotani, S., Kawakita, H., OdaniI, K., Tsutsui, Y., and Nishioka, Y. (2004).
  566. Monarca, S., Donato, F., Zerbini, I., Calderon, R. L., and Craun, G. F. (2006). Review
  567. 95-506.
  568. Morral, N. R., Edenberg, H. J., Witting, S. R., Altomonte, J., Chu, T., and Brown, M.
  569. (2007). Effects of glucose metabolism on the regulation of genes of fatty acid
  570. synthesis and triglyceride secretion in the liver. Journal of Lipid Research 48,
  571. 1499-1510.
  572. Nagata, N., Hiyoshi, M., Shiozawa, H., Shiraishi, K., Watanabe, N., Tsuda, M., and
  573. 11S-14S.
  574. Negre-Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R.,
  575. Penicaud, L., and Casteilla, L. (1997). A role for uncoupling protein-2 as a
  576. Nerbrand, C., Agréus, L., Lenner, R. A., Nyberg, P., and Svärdsudd, K. (2003). The
  577. cells. Journal of Biological Chemistry 278, 31426-31433.
  578. Nishimura, G., Nakahara, K., Misawa, N., Muranaka, M., Uchida, K., Kuroda, H., and
  579. Murakami, N. (2001). Immunization against intestinal bacterial endotoxin
  580. prevents alcoholic fatty liver in rats. Journal of Veterinary Medical Science 63,
  581. 159-173.
  582. Nistor, A., Bulla, A., Filip, D. A., and Radu, A. (1987). The hyperlipidemic hamster
  583. Nguyen, L. B., Shefer, S., Salen, G., Tint, G. S., Ruiz, F., and Bullock, J. (2001).
  584. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of
  585. cholesterol, sitosterol, and lovastatin. Journal of Lipid Research 42, 195-200.
  586. middle-aged men. Japanese Heart Journal 42, 677-690.
  587. Opara, E. C., AbdeI-Rahman, E., Soliman, S., Kamel, W. A., Souka, S., Lowe, J. E.,
  588. Pedersen, C. B., Kyle, J., Jenkinson, A. M., Gardner, P.T., McPhail, D. B., and Duthie, G.G. (2000). Effects of blueberry and cranberry juice consumption on the plasma
  589. antioxidant capacity of healthy female volunteers. European Journal of Clinical
  590. Nutrition 54, 405-408.
  591. health. Clinical Nutrition 25, 377-385.
  592. Polavarapu, R., Spitz , D. R., Sim , J. E., Follansbee, M. H., Oberley, L. W.,
  593. Rahemtulla, A., and Nanji, A. A. (2005). Increased lipid peroxidation and
  594. impaired antioxidant enzyme function is associated with pathological liver injury
  595. in experimental alcoholic liver disease in rats fed diets high in corn oil and fish
  596. Porter, N. A., Caldwell, S. E., and Mills, K. A. (1995). Mechanisms of free radical
  597. oxidation of unsaturated lipids. Lipids 30, 277-290.
  598. Prigneau, O., Porta, A., Poudrier, J. A., Colonna-Romano, S., Noël, T., and Maresca,
  599. B., (2003). Genes involved in β-oxidation, energy metabolism and glyoxylate
  600. Proksch, E., Nissen, H. P., Bremgartner, M., and Urquhart, C. (2005). Bathing in a
  601. skin hydration, and reduces inflammation in atopic dry skin. International
  602. Quinlan, G. J., Lamb, N. J., Evans, T. W., and Gutteridge, J. M. C. (1996).
  603. Ramamurthy, B., Jones, A. D., and Larsson, L. (2003). Glutathione reverses early
  604. effects of glycation on myosin function. American Journal of Physiology 285,
  605. 419-424.
  606. journal of experimental biology 40, 1213-1232.
  607. Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M., and Rice-Evans, C.
  608. decolorization assay. Free Radical Biology and Medicine 26, 1231-1237.
  609. expanded definition. Annual Review of Medicine 44, 121-131.
  610. Reid, I. R., Mason, B., Horne, A. Ames, R., Clearwater, J., Bava, U., Orr-walker, B.,
  611. Wu, F., Evans, M. C., and Gamble, G. D. (2002). Effects of calcium
  612. 1088-1097.
  613. Repa, J. J., and Mangelsdorf, D. J. (2000). The role of orphan nuclear receptors in the
  614. Requena, J. R., Fu, M. X., Ahmed, M. U., Jenkins, A. J., Lyons, T. J., Baynes, J. W.,
  615. and Thorpe, S. R.(1997). Quantification of malondialdehyde and
  616. 4-hydroxynonenal adducts to lysine residues in native and oxidized human
  617. low-density lipoprotein. Biochemical Journal 322, 317-325.
  618. Rice-Evans, C., and Miller, N. J. (1995). Antioxidants-the case for fruit and
  619. vegetables in the diet. British Food Journal 97, 35–40.
  620. Rio, D. D., Stewart, A. J., and Pellegrini, N. (2005). A review of recent studies on
  621. Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W.,
  622. Roglans, N. U., Vil`a, L., Farr’e, M., Alegret, M., S’anchez, R. M., V’azquez-Carrera,
  623. M., and Laguna, J. C. (2007). Impairment of hepatic stat-3 activation and
  624. reduction of PPAR-α activity in fructose-fed rats. Hepatology 45, 778-788.
  625. Romero, F. J., Bosch-Morell, F., Romero, M. J., Jareflo, E. J., Romero, B., Marin, N.,
  626. 143, 456-462.
  627. Rubin, M., Moser, A., Vaserberg, N., Greig, F., Levy, Y., Spivak, H., Ziv, Y., and
  628. Lelcuk, S. (2000). Structured triacylglycerol emulsion, containing both medium-
  629. randomized cross-over study. Journal of Nutrition 16, 95-100.
  630. Rubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G.,
  631. Castagneto, M., and Marescaux, J. (2006). The mechanism of diabetes control
  632. after gastrointestinal bypass surgery reveals a role of the proximal small intestine
  633. 138, 423-425.
  634. Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D.,
  635. and Lin, P. H. (2001). Effects on blood pressure of reduced dietary sodium and
  636. Salah, N., Miller, N. J., Paganga, G., Tijburg, L., and Rice-Evans, C. A. (1995).
  637. chain-breaking antioxidants. Archives of Biochemistry and Biophysics 322,
  638. 339-346.
  639. Sankarapandi, S., and Zweier, J. (1999). Evidence against the generation of free
  640. hydroxyl radicals from the interaction of copper, zinc-superoxide dismutase and
  641. hydrogen peroxide. Journal of Biological Chemistry 274, 34576-34583.
  642. Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J.,
  643. Sterling, R. K., Luketic, V. A., Shiffman, M. L., and Clore, J. N. (2001).
  644. Schulz, J. B., Lindenau, J., Seyfried, J., and Dichgans, J. (2000). Glutathione,
  645. 4904-4911.
  646. Seki, S., Kitada, T., Yamada, T., Sakaguchi, H.,Nakatani, K., and Wakasa, K. (2002).
  647. Shahkhalili, Y., Murset, C., Meirim, I., Duruz, E., Guinchard, S., Cavadini, C. and
  648. Acheson, K. (2001). Calcium supplementation of chocolate: effect on cocoa
  649. butter digestibility and blood lipids in humans. Ameican Journal of Clinical
  650. Nutrition 7, 246-252.
  651. 12, 151-157.
  652. and Chen, Y.C. (2002). In vitro and in vivo inhibitory activities of rutin,
  653. wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and
  654. Sherer, Y., Shaish, A., Levkovitz, H., Keren, P., Janackovic, Z., Shoenfeld, Y., and
  655. Harats, D. (1999). Magnesium fortification of drinking water suppresses
  656. atherogenesis in male LDL-receptor-deficient mice. Pathobiology 67, 207-213.
  657. Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., and
  658. Goldstein, J. L. (1996). Overproduction of cholesterol and fatty acids causes
  659. Sido, B., Hack, V., Hochlehnert, A., Lipps, H., Herfarth, C., and Dröge, W. (1998).
  660. bowel disease. Gut 42, 485-492.
  661. Slatter, D. A., Bolton, C. H., and Bailey, A. J. (2000). The importance of lipid-derived
  662. Slatter, D. A., Murray, M., and Bailey, A. J. (1998). Formation of a dihydropyridine
  663. Sletvold, O., Smaaland, R., and Laerum, O. D. (1991). Cytometry and time-dependent
  664. variations in peripheral blood and bone marrow cells: a literature review and
  665. 235-250.
  666. Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., Mackenzie, K. I., Latour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., Willson, T. M., Koller, B. H., and Kliewer, S. A. (2001). The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences 98, 3369-3374.
  667. Stelzner, M., Hoagland, V., and Somasundaram, S. (2000). Distribution of bile acid
  668. European Journal of Physiology 440, 157-162.
  669. Suji, G., and Sivakami, S. (2008). Malondialdehyde, a lipid-derived aldehyde alters
  670. the reactivity of Cys34 and the esterase activity of serum albumin. Toxicology in
  671. Vitro 22, 618-624.
  672. Suzuki, A., Lindor, K., Saver, J. S., Lymp, J., Mendes, F., Muto, A., Okada, T., and
  673. Teusink, B., Voshol, P.J., Dahlmans, V.E., Rensen, P.C., Pijl, H., Romijn, J.A., and
  674. plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid
  675. uptake. Diabetes 52, 614-620.
  676. Tobian, L. (1997). Dietary sodium chloride and potassium have effects on the
  677. Toyokuni, S. T., Okamoto, K., Yodoi, J., and Hiai, H. (1995). Persistent oxidative
  678. Trautwein, E. A., Rieckhoff, D., and Erbersdobler, H. F. (1998). Dietary insulin
  679. in hamsters. The Journal of Nutrition 128, 1937-1943.
  680. Tukiendorf, A., and Rybak, Z. (2004). New data on ecological analysis of possible
  681. Research 17, 46-52.
  682. Chemistry 114, 1450-1455.
  683. adrenal and beta-cell functions. Diabetes 23, 517-525.
  684. using gene-targeted mice. The Journal of Biological Chemistry 280,
  685. 10877-10880.
  686. VanderLaan, P. A., Reardon, C. A., Thisted, R. A., and Getz, G. S. (2009). VLDL
  687. Journal of Nutritional Biochemistry 14, 492-506.
  688. Vaskonen, T., Mervaala, E., Sumuvuori, V., Seppanen-Laakso, T., and Karppanen, H.
  689. on a low-fat diet. British Journal of Nutrition 8, 239-245.
  690. biosynthesis. Gastroenterology Clinics of North America 28, 1-25.
  691. metabolic syndrome. Journal of Lipid Research 50, 138-143.
  692. Wang, C. C., Chu, C. Y., Chu, K. O., Choy, K. W., Khaw, K. S., Rogers, M. S., and
  693. Pang, C. P. (2004). Trolox-equivalent antioxidant capacity assay versus oxygen
  694. Watanabe, M., Ohtsu, J., and Otsuki, A. (2000). Daily variations in nutrient
  695. concentrations of seawater at 321 m depth in Toyama Bay, Japan Sea. Journal of
  696. Welberg, J. W., Monkelbaan, J. F., de Veries, E. G., Muskiet, F. A., Cats, A., and
  697. Oremus, E. T. (1994). Effects of supplemental dietary calcium on quantitative
  698. 3, 185-191.
  699. Whelton, P. K., He, J., Cutler, J. A., Brancati, F. L., Appel, L. J., and Follmann, D.
  700. Whitehead, T. P., Thorpe, G. H. G., and Maxwell, S. R. J. (1992). Enhanced
  701. Chimica Acta 266, 265-277.
  702. Wierzbicki, M., Chabowski, A., Zendzian-Piotrowska, M., Harasim, E., and Górski, J.
  703. induced by high fat feeding. Advances in Medical Sciences 28, 1-7.
  704. pp 875-897.
  705. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R., and Turner, N. D. (2004). Glutathione
  706. Wynn, J. P., Hamid, A. B. A., and Ratledge, C. (1999). The role of malic enzyme in
  707. 1911-1917.
  708. Yabe, D., Komuro, R., Liang, G., Goldstein, J. L., and Brown, M. S. (2003).
  709. Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for
  710. 3155-3160.
  711. in Taiwan. Environmental Research 101, 407-411.
  712. Yang, C. Y., Cheng, M. F., Tsai, S. S., and Hsieh, Y. L. (1998). Calcium, magnesium,
  713. Cancer Research 89, 124-130.
  714. risk of death from rectal cancer. International Journal of Cancer 77, 528-532.
  715. the risk of death from hypertension. American Journal of Hypertension 12,
  716. 894-899.
  717. breast cancer. Journal of Toxicology and Environmental Health 60, 231-241.
  718. prostate cancer. Journal of toxicology and environmental health 60, 17-26.
  719. Yeon, J. E., Choi, K. M., Baik, S. H., Kim, K. O., Lim, H. J., Park, K. H., Kim, J. Y.,
  720. Park, J. J., Kim, J. S., Bak, Y. T., Byun, K. S., and Lee, C. H. (2004). Reduced
  721. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtmani, E. R., and Mizuno, Y.
  722. Yoshioka, S., Hamada, A., Cui, T., Yokota, J., Yamamoto, S., Kusunose, M.,
  723. Miyamura, M., Kyotani, S., Kaneda, R., Tsutsui, Y., Odani, K., Odani, I., and
  724. Nishioka, Y. (2003). Pharmacological activity of deep-sea water: examination of
  725. Pharmaceutical Bulletin 26, 1552-1559.
  726. Younossi, Z. M., Gramlich, T., Matteoni, C. A., Boparai, N., and Mccullough, A. J.
  727. Radical Biology and Medicine 21, 651-668.
  728. Zechner, R., Strauss, J.G., Haemmerle, G., Lass, A., and Zimmermann, R. (2005).
  729. 333-340.
  730. Zemel, M. B., Shi, H., Greer, B. Dirienzo, D., and Zemel, P. C. (2000). Regulation of
  731. Biology 14, 1132-1138.
  732. Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., and Shaw, J. (2005). The
  733. Journal of Atherosclerosis and Thrombosis 12, 295-300.
  734. Zimmermann, R., Strauss, J. G., Haemmerle, G., Schoiswohl, G.,
  735. promoted by adipose triglyceride lipase. Science 19, 1383-1386.